I'm self-employed http://katkov.dev/cymbalta-medicationnu-a8u0 gsipharma.com Net income for common shareholders in the second quarter rose to $3.57 billion, or 32 cents per share, from $2.10 billion, or 19 cents per share, a year earlier. Revenue, net of interest expense, climbed to $22.73 billion from $21.97 billion.
(携帯) |